|

ex vivo expanded CD4+CD25+CD127- regulatory T cells (Tregs) Clinical Trials

1 actively recruiting trial

Also known as: Tregs, regulatory T cells

Pipeline

Phase 2: 1

Top Sponsors

  • PolTREG S.A.1

Indications

  • Presymptomatic Diabetes Type 1 (Stage 1)1
  • Diabetes Mellitus, Type I1
  • Diabetes Mellitus, Type 11
  • Diabetes1

Other1 trial

Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.